Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Richard Nixon"'
Autor:
Torres Moreno, Richard Nixon, Guarnizo Ante, Fredy Javier, Poveda Aguja Ed, Fernando Augusto, Cruz Mican, Edgar Olmedo, Guzmán Villanueva, Roberto José, Cuervo Polania, José Joaquín
Publikováno v:
Journal of Advanced Zoology; 2023 Supplement, Vol. 44, p1679-1689, 11p
Publikováno v:
Scandinavian Journal of Pain. 16:74-88
Background and aim Diclofenac is widely prescribed for the treatment of pain. Several network meta-analyses (NMA), largely of published trials have evaluated the efficacy, tolerability, and safety of nonsteroidal anti-inflammatory drugs (NSAIDs). The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67309ff6026c2f733f419e117a271641
https://doi.org/10.1016/j.sjpain.2017.03.006
https://doi.org/10.1016/j.sjpain.2017.03.006
Publikováno v:
Repositorio Universidad de las Fuerzas Armadas
Universidad de las Fuerzas Armadas
instacron:ESPE
Universidad de las Fuerzas Armadas
instacron:ESPE
Hoy en día la comunidad mundial enfrenta múltiples conflictos de diferente índole, para lo cual ha sido necesario a través de la Organización de las Naciones Unidas, crear medidas o lineamientos para apaciguar de alguna manera estos conflictos e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::09b11a00a8181739a4c37414876498c4
http://repositorio.espe.edu.ec/handle/21000/20458
http://repositorio.espe.edu.ec/handle/21000/20458
Autor:
Ed Waddingham, Silvia Kuhls, Richard Nixon, Gemma Hodgson, Christoph Dierig, Shahrul Mt-Isa, Thai-Son Tong, Andrew Thomson, John Stuart Pears, Isabelle Stöckert, Kimberley Hockley
Publikováno v:
Biometrical Journal. 58:8-27
While benefit-risk assessment is a key component of the drug development and maintenance process, it is often described in a narrative. In contrast, structured benefit-risk assessment builds on established ideas from decision analysis and comprises a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95d7a73a521d0d1ba20ef49095c9097e
https://doi.org/10.1002/bimj.201300248
https://doi.org/10.1002/bimj.201300248
Autor:
Cuéllar Lemos, Richard Nixon
Publikováno v:
Repositorio UdeA
Universidad de Antioquia
instacron:Universidad de Antioquia
Universidad de Antioquia
instacron:Universidad de Antioquia
RESUMEN: Este trabajo de maestría se realizó en la comunidad indígena Gunadule de Alto Caimán, con cuatro sabios y con los niños y niñas Gunadule del Centro Educativo Rural Alto Caimán. La pregunta de esta investigación fue: ¿Cómo desde la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::d497b359ada69cfa63968a64adcbf7f0
Autor:
Davorka Tomic, Gavin Giovannoni, Richard Nixon, Gary Cutter, Nikolaos Sfikas, Niklas Bergvall
Publikováno v:
Advances in Therapy
Introduction No head-to-head trials have compared the efficacy of the oral therapies, fingolimod, dimethyl fumarate and teriflunomide, in multiple sclerosis. Statistical modeling approaches, which control for differences in patient characteristics, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::671cedde58db890720513cc6bcc40ad6
http://europepmc.org/articles/PMC4245493
http://europepmc.org/articles/PMC4245493
Autor:
Christine E. Hallgreen, Shahrul Mt-Isa, Steve Hobbiger, Marilyn Metcalf, Ioanna Tzoulaki, Davide Luciani, Ruth Peters, Richard Nixon, Lesley Wise, Richard C. Hermann, Alain Micaleff, Ian Hirsch, Deborah Ashby, Isabelle Stoeckert, Hendrika A. van den Ham, Andrew Thomson, Jeremiah Mwangi, Nan Wang, Simon Ashworth, Ed Waddingham, Tjeerd van Staa, Juhaeri Juhaeri, Kimberley Hockley, Gerald Downey
Publikováno v:
Pharmacoepidemiology and Drug Safety. 23:974-983
PURPOSE: Difficulties may be encountered when undertaking a benefit-risk assessment for an older product with well-established use but with a benefit-risk balance that may have changed over time. This case study investigates this specific situation b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5936c678f94a8a99c244d0cb736b4a94
https://doi.org/10.1002/pds.3676
https://doi.org/10.1002/pds.3676
Autor:
A. Karabis, Shaloo Pandhi, Stavros Nikolakopoulos, Katerina Papadimitropoulou, R Andrew Moore, Richard Nixon, Ricardo L. Chaves
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, 18. BioMed Central
Arthritis Research & Therapy, 18. BioMed Central
Background Researchers in clinical trials in rheumatoid arthritis (RA) and osteoarthritis (OA) often measure pain levels with a visual analogue scale (VAS). Of interest to clinical practice and future clinical trial design are associations of change
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2fac467631eb7714685b78103af1b69
https://doi.org/10.1186/s13075-016-0972-7
https://doi.org/10.1186/s13075-016-0972-7
Autor:
Stephane A. Regnier, Richard Nixon, Jonathan M. Wright, Jonathan Alsop, Harry Staines, Franck Fajnkuchen
Aim: To review and compare methods for indirect comparison of aflibercept and ranibizumab in patients with diabetic macular edema. Methods: Post-stratification, inverse probability weighting based on simulated data, weight optimization, and regressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482d848e142d90f68edee98b1f158d7f
Autor:
Edmond S. W. Ng, James R. Carpenter, Richard Nixon, Simon G. Thompson, Richard Grieve, Manuel Gomes
Publikováno v:
Health Economics. 21:1101-1118
Statistical methods have been developed for cost-effectiveness analyses of cluster randomised trials (CRTs) where baseline covariates are balanced. However, CRTs may show systematic differences in individual and cluster-level covariates between the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11c76130f74a25fc223361ffc20d2dc1
https://doi.org/10.1002/hec.2812
https://doi.org/10.1002/hec.2812